Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 960

1.

Cyclins A, B, E and p27 in Endometrial Endometrioid Adenocarcinoma.

Santala S, Talvensaari-Mattila A, Soini Y, Kuvaja P, Santala M.

Anticancer Res. 2016 Dec;36(12):6467-6473.

PMID:
27919969
2.

Clinicopathological significance of loss of p27kip1 expression in papillary thyroid carcinoma.

Kim NY, Kim JH, Pyo JS, Jin Cho W.

Int J Biol Markers. 2017 May 4;32(2):e255-e259. doi: 10.5301/jbm.5000239.

PMID:
27834461
3.

P27/CDKN1B Translational Regulators in Pituitary Tumorigenesis.

Martins CS, Camargo RC, Saggioro FP, Neder L, Machado HR, Moreira AC, de Castro M.

Horm Metab Res. 2016 Dec;48(12):840-846. Epub 2016 Nov 7.

PMID:
27824399
4.

p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.

Pellizzari I, Fabris L, Berton S, Segatto I, Citron F, D'Andrea S, Cusan M, Benevol S, Perin T, Massarut S, Canzonieri V, Schiappacassi M, Belletti B, Baldassarre G.

Oncotarget. 2016 Oct 4;7(40):64560-64574. doi: 10.18632/oncotarget.11656.

5.

Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.

Garcia-Rendueles AR, Rodrigues JS, Garcia-Rendueles ME, Suarez-Fariña M, Perez-Romero S, Barreiro F, Bernabeu I, Rodriguez-Garcia J, Fugazzola L, Sakai T, Liu F, Cameselle-Teijeiro J, Bravo SB, Alvarez CV.

Oncogene. 2017 Feb 2;36(5):652-666. doi: 10.1038/onc.2016.233. Epub 2016 Jul 25.

PMID:
27452523
6.

p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Li Y, Nakka M, Kelly AJ, Lau CC, Krailo M, Barkauskas DA, Hicks JM, Man TK.

Cancer Res. 2016 Jul 1;76(13):4002-11. doi: 10.1158/0008-5472.CAN-15-3189. Epub 2016 Apr 19.

7.

Cryptic sequence features within the disordered protein p27Kip1 regulate cell cycle signaling.

Das RK, Huang Y, Phillips AH, Kriwacki RW, Pappu RV.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5616-21. doi: 10.1073/pnas.1516277113. Epub 2016 May 2.

8.

Prognostic significance of cytoplasmic p27 in oral squamous cell carcinoma.

Vallonthaiel AG, Singh MK, Dinda AK, Kakkar A, Thakar A, Das SN.

J Oral Pathol Med. 2016 Aug;45(7):475-80. doi: 10.1111/jop.12392. Epub 2016 Jan 11.

PMID:
26750594
9.

Genetic Association Between CDKN1B rs2066827 Polymorphism and Susceptibility to Cancer.

Lu Y, Gao K, Zhang M, Zhou A, Zhou X, Guan Z, Shi X, Ge S.

Medicine (Baltimore). 2015 Nov;94(46):e1217. doi: 10.1097/MD.0000000000001217. Review.

10.

Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer.

Lin TC, Tsai LH, Chou MC, Chen CY, Lee H.

Tumour Biol. 2016 Mar;37(3):4017-23. doi: 10.1007/s13277-015-4272-7. Epub 2015 Oct 20.

PMID:
26482622
11.

p27(Kip1) signaling: Transcriptional and post-translational regulation.

Hnit SS, Xie C, Yao M, Holst J, Bensoussan A, De Souza P, Li Z, Dong Q.

Int J Biochem Cell Biol. 2015 Nov;68:9-14. doi: 10.1016/j.biocel.2015.08.005. Epub 2015 Aug 14. Review.

PMID:
26279144
12.

Recurrent CDKN1B (p27) mutations in hairy cell leukemia.

Dietrich S, Hüllein J, Lee SC, Hutter B, Gonzalez D, Jayne S, Dyer MJ, Oleś M, Else M, Liu X, Słabicki M, Wu B, Troussard X, Dürig J, Andrulis M, Dearden C, von Kalle C, Granzow M, Jauch A, Fröhling S, Huber W, Meggendorfer M, Haferlach T, Ho AD, Richter D, Brors B, Glimm H, Matutes E, Abdel Wahab O, Zenz T.

Blood. 2015 Aug 20;126(8):1005-8. doi: 10.1182/blood-2015-04-643361. Epub 2015 Jun 11.

13.

Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

Circelli L, Ramundo V, Marotta V, Sciammarella C, Marciello F, Del Prete M, Sabatino L, Pasquali D, Izzo F, Scala S, Colao A, Faggiano A, Colantuoni V; Multidisciplinary Group for NeuroEndocrine Tumours of Naples.

J Cell Mol Med. 2015 Jul;19(7):1735-41. doi: 10.1111/jcmm.12552. Epub 2015 Mar 30.

14.

PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.

Prasad SB, Yadav SS, Das M, Modi A, Kumari S, Pandey LK, Singh S, Pradhan S, Narayan G.

Cell Oncol (Dordr). 2015 Jun;38(3):215-25. doi: 10.1007/s13402-015-0224-x. Epub 2015 Mar 28.

PMID:
25821107
15.

Validation of p27KIP1 expression levels as a candidate predictive biomarker of response to rapalogs in patient-derived breast tumor xenografts.

Ding XF, Yin DQ, Chen Q, Zhang HY, Zhou J, Chen G.

Tumour Biol. 2015 Mar;36(3):1463-9. doi: 10.1007/s13277-014-2580-y. Epub 2015 Mar 7.

PMID:
25744729
16.

Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.

Crona J, Gustavsson T, Norlén O, Edfeldt K, Åkerström T, Westin G, Hellman P, Björklund P, Stålberg P.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1428-35. doi: 10.1245/s10434-014-4351-9. Epub 2015 Jan 14.

PMID:
25586243
17.

Immunohistochemical expression of p27(kip1) in metastatic laryngeal squamous cell carcinoma.

Bodnar M, Szylberg Ł, Kaźmierczak W, Marszałek A.

Adv Med Sci. 2014 Sep;59(2):206-12. doi: 10.1016/j.advms.2014.03.005. Epub 2014 Jun 9.

PMID:
25323759
18.

p27 and leukemia: cell cycle and beyond.

Roy A, Banerjee S.

J Cell Physiol. 2015 Mar;230(3):504-9. doi: 10.1002/jcp.24819. Review.

PMID:
25205053
19.

Brachyury regulates proliferation of cancer cells via a p27Kip1-dependent pathway.

Jezkova J, Williams JS, Jones-Hutchins F, Sammut SJ, Gollins S, Cree I, Coupland S, McFarlane RJ, Wakeman JA.

Oncotarget. 2014 Jun 15;5(11):3813-22.

20.

Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility.

Murali A, Nalinakumari KR, Thomas S, Kannan S.

Br J Oral Maxillofac Surg. 2014 Sep;52(7):652-8. doi: 10.1016/j.bjoms.2014.05.010. Epub 2014 Jun 16.

PMID:
24947332

Supplemental Content

Support Center